Emerald Medical Applications Corp. - Statements of Operations	12 Months Ended
	Dec. 31, 2015 USD ($) $ / shares shares	Dec. 31, 2014 USD ($) $ / shares shares
Statements of Operations
Revenue	$ 0	$ 0
Expenses:
Research and development	(740,197)	0
General and administrative expenses	(7,296,798)	(116,863)
Total operating expenses	(8,036,995)	(116,863)
(Loss) from operations	(8,036,995)	(116,863)
Other income (expense):
Depreciation expense	(6,494)	(66)
Interest expense	(30,604)	(5,605)
Change in fair value of derivative	$ 0	$ (7,385)
Gain/loss from foreign currency	(4,147)	3,877
Other income from grants	0	20,993
Loss on settlement of debt	(678,027)	0
Other income (expense)	$ (719,272)	$ 11,814
Total income (expense)	(8,756,267)	(105,049)
Provision for income taxes	0	0
Net (loss)	$ (8,756,267)	$ (105,049)
Basic and diluted net loss per share | $ / shares	$ (0.81)	$ (0.01)
Weighted average shares outstanding
Basic and diluted | shares	10,872,526	7,348,141